Skip to main content

SARS RDRP Antibody (4E6) [Janelia Fluor® 669]

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-50258JF669

Novus Biologicals, part of Bio-Techne

Key Product Details

Species Reactivity

Validated:

SARS-CoV

Predicted:

SARS-CoV-2 (96%). Backed by our 100% Guarantee.

Applications

Western Blot

Label

Janelia Fluor 669

Antibody Source

Monoclonal Mouse IgG1 Clone # 4E6

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Product Specifications

Immunogen

The antibody was developed by immunizing mice with a GST fusion protein corresponding to Replicase polyprotein 1ab for the Human SARS coronavirus (Genbank accession no. NP_828849.2)

Reactivity Notes

Immunogen displays the following percentage of sequence identity for non-tested species: COVID-19 (96%)

Clonality

Monoclonal

Host

Mouse

Isotype

IgG1

Applications for SARS RDRP Antibody (4E6) [Janelia Fluor® 669]

Application
Recommended Usage

Western Blot

Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Protein A purified

Formulation

50mM Sodium Borate

Preservative

0.05% Sodium Azide

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C in the dark.

Background: SARS RDRP

Additional SARS RDRP Products

Product Documents for SARS RDRP Antibody (4E6) [Janelia Fluor® 669]

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for SARS RDRP Antibody (4E6) [Janelia Fluor® 669]



Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...